(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AVERITAS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

AVERITAS

ST13

US500000097978643

Class

5, 44

Filing

97978643

Registration

7531917

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

10/08/2024

Trademark type

Combined

Nice classes

5, 44

Filing date

02/09/2023

Registration date

10/08/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/08/2024

Last transaction

10/08/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/16/2023

First use in commerce

10/16/2023

Drawing code

3

Owner type

03

Owner location

Morristown, NJ, US

Examiner

CASE, LEIGH

Law office

M30

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "Averitas" on the right side and a concentric circular design made up of dots on the left, and the dots partially encircles the letters "Av".

Holders and representatives

Holders

Averitas Pharma, Inc.

Representatives

Paul C. Llewellyn ARNOLD & PORTER KAYE SCHOLER LLP

Technical classification

Nice Classes

Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of pain; Pharmaceutical preparations for the treatment of viralmetabolicendocrineneurological diseases and disorders.

Class 44

Medical servicesproviding and supplying of information in the healthcare field of pain treatment; providing website portals on the internet featuring information in the healthcare field of pain treatment; providing online information in the healthcare field of pain treatment

Publications

History of USPTO decisions and trademark events.

28 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/08/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

10/08/2024

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

08/29/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/29/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/29/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/12/2024

DPCC

DIVISIONAL PROCESSING COMPLETE

08/12/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/08/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/06/2024

EX1G

SOU EXTENSION 1 GRANTED

08/06/2024

EEXT

SOU TEAS EXTENSION RECEIVED

08/06/2024

EXT1

SOU EXTENSION 1 FILED

08/02/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/02/2024

INCD

ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST

07/08/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/04/2024

IUAF

USE AMENDMENT FILED

05/02/2024

DRRR

DIVISIONAL REQUEST RECEIVED

05/02/2024

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

05/02/2024

EISU

TEAS STATEMENT OF USE RECEIVED

05/02/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/06/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/12/2023

PUBO

PUBLISHED FOR OPPOSITION

12/12/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/22/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/09/2023

DOCK

ASSIGNED TO EXAMINER

11/08/2023

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

03/01/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/28/2023

NWAP

NEW APPLICATION ENTERED

02/13/2023

Continuous trademark protection

Get notified about every new filing that threatens AVERITAS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.